INFIQ (Infinity Pharmaceuticals) Market Cap: $0.00 Mil (As of Jul. 04, 2026)


INFIQ Infinity Pharmaceuticals Inc INFIQ
16 GF Score
Price $0.00
View Full Analysis

What is Infinity Pharmaceuticals Market Cap?

Infinity Pharmaceuticals INFIQ -99.00% 16 Market Cap is $0.00 Mil as of Jul. 04, 2026. GuruFocus rates INFIQ with a GF Score™ of 16/100.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Infinity Pharmaceuticals's share price for the quarter that ended in Jun. 2023 was $0.2105. Infinity Pharmaceuticals's Shares Outstanding (EOP) for the quarter that ended in Jun. 2023 was 90.76 Mil. Therefore, Infinity Pharmaceuticals's market cap for the quarter that ended in Jun. 2023 was $19.11 Mil.

Infinity Pharmaceuticals's quarterly market cap declined from Dec. 2022 ($49.62 Mil) to Mar. 2023 ($14.31 Mil) but then increased from Mar. 2023 ($14.31 Mil) to Jun. 2023 ($19.11 Mil).

Infinity Pharmaceuticals's annual market cap increased from Dec. 2020 ($136.36 Mil) to Dec. 2021 ($200.60 Mil) but then declined from Dec. 2021 ($200.60 Mil) to Dec. 2022 ($49.62 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Infinity Pharmaceuticals's Enterprise Value for Today is $0.00 Mil.

Infinity Pharmaceuticals  (OTCPK:INFIQ) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Infinity Pharmaceuticals Market Cap Related Terms

Infinity Pharmaceuticals Market Cap Historical Data

* Premium members only.

The historical data trend for Infinity Pharmaceuticals's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Infinity Pharmaceuticals Market Cap Chart

Infinity Pharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 67.15 54.79 136.36 200.60 49.62

Infinity Pharmaceuticals Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.45 106.32 49.62 14.31 19.11

INFIQ vs CLCS, RVLPQ, IVRN: Market Cap Comparison

For the Biotechnology subindustry, Infinity Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Infinity Pharmaceuticals Market Cap vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Infinity Pharmaceuticals's Market Cap distribution charts can be found below:

* The bar in red indicates where Infinity Pharmaceuticals's Market Cap falls into.


INFIQ
16GF Score
Infinity Pharmaceuticals Inc INFIQ
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Infinity Pharmaceuticals Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Infinity Pharmaceuticals's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as

Market Cap (A: Dec. 2022 )=Share Price (A: Dec. 2022 )*Shares Outstanding (EOP) (A: Dec. 2022 )
=$0.555*89.411
=$49.62

Infinity Pharmaceuticals's Market Cap for the quarter that ended in Jun. 2023 is calculated as

Market Cap (Q: Jun. 2023 )=Share Price (Q: Jun. 2023 )*Shares Outstanding (EOP) (Q: Jun. 2023 )
=$0.2105*90.761
=$19.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of $0.00 Mil mean?
Infinity Pharmaceuticals (INFIQ) has a Market Cap of $0.00 Mil as of Jul. 04, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Infinity Pharmaceuticals and its competitors.
Is Infinity Pharmaceuticals' Market Cap too high?
Infinity Pharmaceuticals' current Market Cap is $0.00 Mil. Overall, Infinity Pharmaceuticals has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Infinity Pharmaceuticals' Market Cap compare to CLCS and RVLPQ?
Infinity Pharmaceuticals' Market Cap of $0.00 Mil can be compared against companies in the Biotechnology industry. The industry median Market Cap is 119.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 119.23, based on 1,426 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Infinity Pharmaceuticals and its competitors. For the Biotechnology industry, the median Market Cap is 119.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Infinity Pharmaceuticals's current Market Cap is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Infinity Pharmaceuticals stock overvalued right now?
Infinity Pharmaceuticals (INFIQ) has a current Market Cap of $0.00 Mil. The current Market Cap is $0.00 Mil. Infinity Pharmaceuticals' overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Infinity Pharmaceuticals (INFIQ), the current Market Cap is $0.00 Mil as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Infinity Pharmaceuticals Business Description

Address 1100 Massachusetts Avenue, Floor 4, Cambridge, MA, USA, 02138
Infinity Pharmaceuticals Inc is a clinical-stage biopharmaceutical company dedicated to developing novel medicines for people with cancer. It combines proven scientific expertise with a passion for developing novel small molecule drugs that target disease pathways for potential applications in oncology. It is focused on advancing eganelisib, also known as IPI-549, an orally administered, clinical-stage, immuno-oncology product candidate that reprograms macrophages through selective inhibition of the enzyme phosphoinositide-3-kinase-gamma, or PI3K-gamma.
16GF Score

Get the complete analysis for INFIQ

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price